Term
|
Definition
| EGYPTIAN IMHOTEP 3000BC EGYPTTIAN GOD OF MEDICINE |
|
|
Term
| PHYSICIAN OATH WRITTEN BY KNOWN AS |
|
Definition
| HIPPOCRATES GREEK DR 400BC KNOWN AS THE HIPPOCRATICN OATH |
|
|
Term
|
Definition
| DISEASE AND PESTILENCE PANDORA BOX GIVEN BY ZEUS AS PENALTY FOR PROMETHEUS THEFT OF FIRE FOR MAN |
|
|
Term
|
Definition
| WITH CHEMICALS COMBINING SIMPLER CHEMICALS INTO MORE COMPLEX COMPOUNDS CREATING A NEW CHEMICAL NOT FOUND IN NATURE AS A RESULT |
|
|
Term
|
Definition
ANCIENT GREEK AESCULAPIUS TO BE EXTRAORDINARY DR ANGERED PLUTO AT HIS REQUEST ZEUS KILLED AESCULAPIUS AND NAMED HIM GOD OF MEDICINE AESCULAPIUS
DAUGHTER PANACEA BECAME THE GOD OF MEDICINAL HERBS |
|
|
Term
|
Definition
| MALARIA FROM THE BARK OF THE PERUVIAN TREE THE CINCHONA ALSO CALLED JESUIT'S POWDER 1630AD |
|
|
Term
|
Definition
THE FIRST ANESTHETIC INDIAN ANDES CHEWED COCA LEAVES FOR ENERGY USED IN
1884 BY CARL KOLLER A VIENNESE SURGEON
REVOLUTIONIZED BOTH SURGERY AND DENISTRY |
|
|
Term
|
Definition
| MAN MADE SUBSTITUTE FOR COCAINE TO USED FOR ANESTHESIA AFTER COCAINE HARMFUL PROPERTIES REALIZED |
|
|
Term
|
Definition
| SALICYLIC ACID FROM THE BARK OF THE WHITE WILLOW TREE NOTED BY HIPPOCRATES AND DIOSCORIDES |
|
|
Term
|
Definition
POPULARLY KNOW AS ASPIRIN DEVELOPED AS A CHEMICAL SUBSTITUTE FOR SALICYCLIC
ACID DUE TO DIFFICULTIES IN TAKING IT
INTERNALLY 1899 |
|
|
Term
|
Definition
| USED ABOUT 250 NATURAL MEDICINES DERIVED FROM PLANTS MANY STILL USED TODAY 4000BC |
|
|
Term
| CHINESE EMPEROR SHEN NUNG |
|
Definition
| BEGAN EATING PLANTS AND OTHER NATURAL MATERIALS TO DETERMINE WHICH WERE POISONOUS AND WHICH WERE BENEFICIAL FIRST KNOWN TO USE TRIAL AND ERROR DRUG TESTING ESTABLISHED OVER 365 HERBS EXPANDED LATER BY OTHER CHINESE PHYSICIANS IE HERBAL MEDICINE 3000BC |
|
|
Term
| WHY USE SYNTHETIC DRUGS (3) |
|
Definition
| ADVANTAGES IN COST,EFFECT AND AVAILABILITY |
|
|
Term
|
Definition
| 1500 BC MOST COMPLETE RECORD OF ANCIENT EGYPTIAN MEDICINE AND PHARMACOLOGY 1100PGS 800 SCRIPTS 700 DRUGS MOSTLY ALL FROM PLANTS |
|
|
Term
|
Definition
| GREEK STUDENT OF PYTHAGORUS SAW DISEASES AS LOSS OF ONE'S EQUILIBRIUM |
|
|
Term
|
Definition
| 400BC ACTUALLY MANY WORKS ARE WRITTEN BY DIFFERENT GREEK PHYSICIANS UNDER THE SAME NAME HIPPOCRATES AVOID SUPERNATURAL AND RELIGIOUS AND USES SCIENTIFIC REASONING AND CLOSE OBSERVATION INCLUDES THE FAMOUS HIPPOCRATIC OATH |
|
|
Term
|
Definition
| 600 BC ESTABLISHED CENTERS WHERE MEDICINE WAS PRACTICED EARLY CLINICS THAT BECAME TRAINING GROUNDS FOR GREEK DRS OF LATER YEARS |
|
|
Term
|
Definition
| STUDY OF DRUGS THEIR PROPERTIES USES APPLICATIONS AND EFFECTS FROM THE GREEK PHARMAKON DRUG AND LOGOS WORK OR THOUGHT |
|
|
Term
|
Definition
| DERIVED FROM THE GREEK WORDS PHARMKON OR DRUG AND GNOSIS OR KNOWLEDGE THE STUDY OF PHYSICAL CHEMICAL BIOCHEMICAL AND BIOLOGICAL PROPERTIES OF DRUGS FROM NATURAL SOURCES |
|
|
Term
|
Definition
| GENERALLY PHARMACOLOGY BUT ALSO REFERS TO THE DRUGS IN USE(FROM THE LATIN MATERIA MATTER AND MEDICA MEDICAL) |
|
|
Term
| KING MITHRIDATES OF PONTOS |
|
Definition
| PRACTICED EARLY FORM OF IMMUNIZATION BY TAKING SMALL AMOUNTS OF POISONS SO THAT HE COULD BUILD HIS TOLERANCE TO THEM DEVELOPED MITHRIDATICUM A POTION BELIEVED TO BE GOOD AT PROMOTING HEALTH AND USED FOR 1500 YEARS 100BC |
|
|
Term
|
Definition
| 77BC GREEK PHYSICIAN WORKING IN THE ROMAN LEGION WROTE THE DE MATERIA MEDICA FIVE BOOKS DESCRIBING OVER 600 PLANTS AND THEIR HEALING PROPERTIES MAIN INFLUENCE OVER WESTERN PHARMACEUTICS FOR OVER 1600 YEARS |
|
|
Term
|
Definition
| GREEK DR WENT TO ROME BOTH HIS PRACTICE AND WRITINGS NEARLY 100 OF WHICH SURVIVE BELIEVED THERE WERE FOUR HUMOURS IN MAN WHICH NEEDED TO BE IN BALANCE FOR GOOD HEALTH AND HE ADVOCATED BLEEDING TO ASSIST THAT BALANCE ALSO BELIEVED IN VIGOUROUS APPLICATION OF SCIENTIFIC APPROACH TO MEDICINE AND EMPHASIS ON EDUCATION OBSERVATION LOGIC FORMED CORNERSTONE OF WESTERN MEDICINE 162AD |
|
|
Term
|
Definition
| 200BC LISTS 365 HERBS FOR USE IN HEALTH TX EARLY CHINESE FORERUNNER TO FDA APPROVED DRUG LIST |
|
|
Term
|
Definition
| INDIAN PHYSICIAN CHARAKA FIRST GREAT BOOK OF INDIAN MEDICINE INCLUDES DESCRIPTION OF OVER 500 HERBAL DRUGS KNOWN AND USED IN INDIA MANY CENTURIES |
|
|
Term
|
Definition
| AUTHORITATIVE LISTING OF DRUGS AND ISSUES RELATED TO THEIR USE |
|
|
Term
|
Definition
| OF OR ABOUT DRUGS ALSO A DRUG PRODUCT |
|
|
Term
|
Definition
| A CURE ALL FROM THE GREEK PANAKEIA SAME MEANING OR THE GREEK GODESS OF MEDICINAL HERBS |
|
|
Term
|
Definition
| POPULAR TESTBOOK OF MEDICINE IN THE MEDICAL AGES THE BOOK OF MEDICINE DEDICATED TO MANSUR MAN OF SCIENCE HE WAS ALSO AN ALCHEMIST WHO BELIEVED HE COULD TURN LESSES METAL INTO GOLD WHEN HE FAILED TO DO THIS IT WAS ORDERED THAT HE BE BEAT OVER THE HEAD WITH HIS OWN BOOK BOOK BROKE AND HE WENT ON TO CONTINUE HIS WORK 900AD |
|
|
Term
|
Definition
| 1500AD HAD A PHARMACOLOGY MORE THAN 1200 DRUGS CLEARLY RESULT OF PRACTICE EX SAPARILLA USE OF KIDNEY AND BLADDER AILMENTS AND USED IN MANY MEDICINAL TEAS |
|
|
Term
|
Definition
| CHINA 1580AD COMPLETED BY LI SHI ZHEN NEARLY 2000 DRUGS FOR USE IN TX ILLNESS AND OTHER CONDITIONS |
|
|
Term
|
Definition
| GREATEST ISLAMIC DR 5 VOL ENCYCLOPEDIA ONE OF WHICH WA DEVOTED TO NATURAL MEDICATIONS AND ANOTHER TO COMPOUNDING DRUGS FROM INDIVIDUAL MEDS 1000AD |
|
|
Term
|
Definition
| 1500 AD SWISS ALCHEMIST REJECTED HUMOURAL PHILOSOPHY OF GALEN AND ALL OTHER EXCEPT HIPPOCRATES CREDITED WITH FIRMLY ESTABLISHING USE OF CHEMISTRY TO CREATE MEDICINAL DRUGS |
|
|
Term
|
Definition
| DEVELOPED THE FIRST SMALLPOX VACCINE(HE HAD HAD IT AS A CHILD AND LIVED)1721AD |
|
|
Term
|
Definition
| 1796 SUCCESSFULLY USES A VACCINE FROM THE MILDER COWPOX TO INNOCULATE AGAINST SMALLPOX |
|
|
Term
|
Definition
| SUBSTANCE THAT ACTS AGAINST A TOXIN IN THE BODY ALSO A VACCINE CONTAINING ANTITOXINS USED TO FIGHT DISEASE |
|
|
Term
|
Definition
| A SUBSTANCE WHICH HARMS OR KILLS MICROORGANISMS LIKE BACTERIA OR FUNGI |
|
|
Term
|
Definition
| CHEMICALS PRODUCED BY THE BODY THAT REGULATE BODY FUNCTION AND PROCESSES |
|
|
Term
|
Definition
| THE COMPLETE SET OF GENETIC MATERIAL CONTAINED IN A HUMAN CELL |
|
|
Term
|
Definition
| 1785AD BRITISH DR FOXGLOVE PLANT DIGITALIS FOR HEART DISEASE ESTABLISHED A PROCESS FOR CREATING THE DRUG FROM THE DRIED LEAVES AND ESTABLISHED A DOSAGE APPROACH |
|
|
Term
|
Definition
| FROM THE FOXGLOVE PLANT USED TO TREAT AMONG OTHER THINGS HEART DISEASE |
|
|
Term
|
Definition
| 1803 GERMAN PHARMACIST EXTRACT MORPHINE FROM OPIUM |
|
|
Term
|
Definition
|
|
Term
|
Definition
| USED IN 1ST PUBLICIZED OPERATION USING GENERAL ANESTHESIA 1856 IN BOSTON |
|
|
Term
| CHARLES BEST AND FREDERICK BANTING |
|
Definition
| 1921 SHOWED EXTRACT OF THE HORMONE INSULIN WOULD LOWER BLOOD SUGAR (ON DOGS) |
|
|
Term
|
Definition
| 1921 BIOCHEMIST DEVELOPED EXTRACT OF INSULIN PURE ENOUGH TO BE TESTED IN HUMANS FIRST HUMAN TRIAL IN 1922 |
|
|
Term
|
Definition
| 1957 DEVELOPS AN ORAL POLIO VACCINE(USING A WEAKENED LIVE VIRUS) USED UNTIL JAN 2000 AFTER WHICH ONLY THE INJECTED FORM IS NOW USED DUE TO THE RISK OF AN ASSOC DISEASE |
|
|
Term
|
Definition
|
|
Term
| FIRST DOCUMENTED CASE OF AIDS |
|
Definition
|
|
Term
|
Definition
| 1987 FIRST DRUG APPROVED BY THE FDA FOR AIDS TX |
|
|
Term
|
Definition
| 1864 EXPERIEMENTS SHOWED THAT MICROORGANISMS CAUSE FOOD SPOILAGE THAT HEAT CAN BE USED TO KILL THEM AND PRESERVE THE FOOD GERM THEORY HE IS NOT THE FIRST TO USE GERM THERAPY BUT IS WHO'S WORK THAT INSTRUMENTAL TO BEING WIDELY ACCEPTED |
|
|
Term
|
Definition
| 1884 VIENNESE SURGEON DISCOVERS COCAINE USEFUL AS LOCAL ANESTHETIC IN EYE SURGERY AND ESTABLISHED IT AS THE FIRST LOCAL ANESTHETIC |
|
|
Term
|
Definition
| 1890 EFFECTIVE ANTITOXINS ARE DEVELOPED FOR DIPTHERIA AND TETANUS GIVES MAJOR BOOST TO DEVELOPMENT OF MEDICINES THAT FIGHT INFECTIOUS DISEASE |
|
|
Term
|
Definition
| 1928 DISCOVERS FUNGUS WHICH PRODUCES A CHEMICAL THAT KILLS BACTERIA NAMES IT PENICILLIN IT IS THE FIRST ANTIBIOTIC DRUG |
|
|
Term
|
Definition
FIRST ANTIBIOTIC DRUG USED TO KILL BACTERIA IT IS PRODUCED BY A FUNGUS
1928 |
|
|
Term
|
Definition
| 1943 CREATED HORMONE PROGESTERONE FROM THE MEXICAN YAM FIRST RELIABLE BIRTH CONTROL DRUG |
|
|
Term
|
Definition
| 1943 FIRST RELIABLE BIRTH CONTROL DRUG FROM THE MEXICAN YAM |
|
|
Term
| JAMES WATSON AND FRANCIS CRICK |
|
Definition
| IDENTIFY THE STRUCTURE OF DNA 1951 |
|
|
Term
|
Definition
| BASIC COMPONENT WITHIN THE CELL THAT CONTAINS THE ORGANISMS GENECTIC CODE |
|
|
Term
|
Definition
| 1955 SUCCEEDS IN DEVELOPING A REFINED INJECTABLE POLIO VACCINE (IN 1954 >13000DIED AND >18000 CRIPPLED FROM POLIO |
|
|
Term
|
Definition
| 1988 GOAL MAPPING THE ENTIRE DNA SEQUENCE IN THE HUMAN GENOME TO PROVIDE A BETTER UNDERSTANDING OF HERERITARY DISEASES AND DEVELOPMENT OF NEW TX FOR THEM |
|
|
Term
|
Definition
| 1989 AMGEN DEVELOPS PRODUCTS BASED ON ADVANCES IN CELLULAR AND MOLECULAR BIOLOGY AND INTRODUCES ITS FIRST PRODUCT EPOGEN AN ANEMIA TX FOR DIALYSIS PTS |
|
|
Term
|
Definition
| 1989 ANEMIA TX FOR DIALYSIS PATIENTS FIRST PRODUCT BY BIOTECHNOLOGY CO CALLED AMGEN |
|
|
Term
|
Definition
| 1996 HIGHLY ACTIVE ANTI RETROVIRAL THERAPY INTRODUCED FOR AIDS TX COMBO OF PROTEASE INHIBIT0R (ONE) AND ANTIRETROVIRAL (TWO) EFFECTIVE IN SLOWING DOWN HIV PROGRESS AND PARTIALLY RESPONSIBLE FOR THE 47%< AIDS DEATH RATE IN 1997 |
|
|
Term
|
Definition
|
|
Term
|
Definition
| >OVER 20 YRS 20TH CENTURY |
|
|
Term
| MAJOR FACTOR IN THE INCREASED HEALTH AND LIFE EXPECTANCY THIS CENTURY |
|
Definition
| DRAMATIC GROWTH IN THE TWENTIETH CENTURY |
|
|
Term
|
Definition
AIDED IN THE WORLD WAR AND SAVED LIVES
AS IT PREVENTED INFECTIONS US CO PFIZER HELPED THE BRITISH ALREADY UNDER ATTACK AND UNABLE TO MASS PRODUCE PENICILLIN |
|
|
Term
|
Definition
| COMPANY HOLDING THE PATENT ABLE TO CONTROL THE MARKETING OF THE PRODUCT AND USE THIS AS A WAY TO RECOVER THEIR ORIGINAL INVESTMENT USUALLY OCCURS LONF BEFORE A DRUG IS APPROVED HOWEVER A CO GENERALLY ONLY HAS ABOUT 10YRS OF PATENT PROTECTION LEFT TO MARKET THEIR PRODUCT WITHOUT COMPETITION FROM DIRECT COPIES OR GENERICS |
|
|
Term
| REGULATION IMPORTANT DUE TO |
|
Definition
| INCREASED AVAILABILITY OF POWERFUL DRUGS |
|
|
Term
|
Definition
PERFORMS DRUG REGULATION IN THE US
FDEA IS REQUIRED TO ENSURE THAT A DRUG IS SAFE AND EFFECTIVE FOR INTENDED USE
TO MONITOR A DRUG AFTER IT IS MARKETED TP ENSURE IT WORKS AS INTENDED
TO MONITOR A DRUG FOR ANY ADVERSE EFFECTS |
|
|
Term
|
Definition
| REQUIRES A MAJOR INVESTMENT OF TIME RESEARCH AND DEVELOPMENT PHARM INDUSTRY DEVOTES ABOUT ONE/SIXTH OF ITS INCOME TO RESEARCH AND DEVELOPMENT LENGTH OF TIME FROM THE BEGINNING OF DEVELOPMENT THROUH TESTING TO FDA APPROVAL IS OFTEN MORE THAT TEN YEARS |
|
|
Term
|
Definition
| HAS BECOME ONE OF THE MOST DYNAMIC AREA OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT |
|
|
Term
|
Definition
| ONE THAT HAS BEEN ORDERED AND PRESCRIBED BY DR OR OTHER LISCENCED PRESCRIBER TO TX A PT |
|
|
Term
|
Definition
| RATED AS THE MOST HIGHLY TRUSTED PROFESSIONALS IN THE US |
|
|
Term
|
Definition
| 1990 US CONGRESS REQUIRES PHARMACISITS TO PROVIDE COUNSELING SERVICES TO MEDICAID PATIENTS IN THE OMNIBUS BUDGET RECONCILIATION ACT |
|
|
Term
| PRESCRIPTIONS FILLED 1999-->2005 |
|
Definition
| >BY 24% while #pharm >14% |
|
|
Term
| LARGEST TO SMALLEST AREA OF EMPLOYMENT FOR PHARMACISTS AND PHARM TECH |
|
Definition
COMMUNOTY PHARMACIES
HOSPITALS
MAIL ORDER PHARMACIES
LONG TERM CARE
MANAGED CARE
HOME CARE |
|
|
Term
| 3 RESULTS OF MANAGED CARE FOR PHARMACY INDUSTRY |
|
Definition
MAJORITY OF SCRIPTS ARE PAID BY PRIVATE 3RD PARTIES IE HMO+INS CO INSTEAD OF DIRECTLY BY CONSUMER
USE OF CLOSED FORMULARIES RELY HEAVILY ON GENERICS
THERAPEUTIC SUBSTITUTION WHERAS A CHEMICALLY SIMILAR DRUG IS USED USUALLY BECAUSE IT IS CHEAPER |
|
|
Term
| PHARMACY COMPUTER SYSTEMS |
|
Definition
HAVE POWERFUL COMPTERIZED TOOLS THAT HELP PRODUCTIVITY
SYSTEM MAY BE DEVELOPED BY USER TO MEET SPECIFIC NEEDS PURCASED READYMADE OR PROVIDED BY A WHOLESALER
ALTHOUGH EACH PHARMACY COMPUTER SYSTEM HAS ITS OWN SPECIFIC FEATURES MANY GENERAL PRINCIPLES OF COMPUTER USAGE APPLY TO ALL SYSTEMS |
|
|
Term
|
Definition
| CONSIDERING HOW MUCH DATA ENTRY IS REQUIRED BEING ABLE TO TYPE AT LEAST 45WPM IMPORTANT SKILL |
|
|
Term
|
Definition
| MANY SYSTEMS USE PERSONAL COMPUTERS OR SIMILAR CUSTOM HARDWARE SO FAMILIARITY WITHUSING COMPUTERS IS IMPORTANT |
|
|
Term
|
Definition
| INFORMATION THAT IS ENTERED INTO AND STORED IN A COMPUTER SYSTEM |
|
|
Term
| COMPUTER SYSTEM PHARMACY INCLUDES(10) |
|
Definition
PATIENTS PROFILE
BILLING
MANAGEMENT REPORTING
PRESCRIBER PROFILE
EDUCATION COUNSELING
PRODUCT SELECTION
INVENTORY
PRICING
SECURITY
LABELING |
|
|
Term
|
Definition
INCLUDES PREESCRIBERS
INSURER
MEDS HX
MEDICAL HX INC ALLERGIES
DRUG INTERACTIONS FOR PATIENTS TAKING MULTIPLE MEDS |
|
|
Term
|
Definition
| CHECKS POLICIES OF THIRD PARTIES SUCH AS HMO AND INSURERS,AUTHORIZES 3RD PARTY TRANSACTIONS AND CREDIT CARD ELECTRONICALLY |
|
|
Term
|
Definition
| FORECASTING FINANCIAL ANALYSIS |
|
|
Term
|
Definition
| INCLUDES STATE IDENTIFICATION NUMBERS AND AFFILIATIONS W/FACILITIES AND INSURERS |
|
|
Term
|
Definition
| PATIENT INFO ABOUT DRUGS USAGE INTERACTIONS ALLERGIES ETC |
|
|
Term
|
Definition
| LOCATES ITEMS BY VARIOUS MEANS IE BRAND NAME GENERIC NAME PRODUCT CODE CATEGORY SUPPLIER ETC GIVES UPDATES OF PRICES AND OTHER PROCUCT INFO |
|
|
Term
|
Definition
| ADJUSTS INVENTORY AS PRESCRIPTIONS ARE FILLED ANALYZES TURNOVER PRODUCES STATUS REPORTS AUTOMATICALLY REORDERS BASED ON INVENTORY LEVELS GENERATES PURCHASE ORDERS |
|
|
Term
|
Definition
| PROVIDES PRICES FOR MEDICATIONS AND POSSIBLE SUBSTITUTES AUTOMATICALLY UPDATES PRICES SCANS PRICES FROM BAR CODES |
|
|
Term
|
Definition
| PASSWORD PROTECTION RESTRICTS ACCESS TO AUTHORIZED USERS FOR DIFFERENT FEATURES |
|
|
Term
|
Definition
| CREATES LABEL RECEIPT CUSTOMER INFORMATION AND USAGE INSTRUCTIONS |
|
|
Term
|
Definition
PEOPLE HAVE USED DRUGS DERIVED FROM PLANTS TO TREAT ILLNESS AND OTHER PHYSIDAL CONDITIONS FOR THOUSANDS OF YEARS
THE ANCIENT GREEKS USED THE BARK OF A WHITE WILLOW TREE TO RELIEVE PAIN THE BARK CONTAINED SALICYCLIC ACID THE NATURAL FORERUNNER OF THE ACTIVE INGREDIENT ASPIRIN
COCAINE WAS THE FIRST EFFECTIVE LOCAL ANESTHETIC |
|
|
Term
| KC-1 MEDICINE THROUGH THE AGES |
|
Definition
THE FOXGLOVE PLANT CONTAINS THE DRUG DIGITALIS WHICH HAS BEEN WIDELY USED IN TREATING HEART DISEASE
LOUIS PASTEUR EXPERIMENTS SHOW THAT MICROORGANISMA CAUSE FOOD SPOILAGE AND THAT HEAT CAN BE USED TO KILL THEM AND PRESERVE THE FOOD
FREDERICK BANTING AND CHARLES BEST SHOWED THAT THE EXTRACT OF THE HORMONE INSULIN LOWERED BLOOD SUGAR IN DOGS AND MIGHT BE USEFUL IN THE TREATMENT OF DM
ALEXANDER FLEMING DISCOVERED THE ANTIBIOTIC CHEMICAL PENNICILLIN
THE HUMAN GENOME PROJECT IS AN ATTEMPT TO MAP THE ENTIRE DNA SEQUENCE IN THE HUMANE GENOME THIS INFORMATION WILL PROVIDE A BETTER UNDERSTANDING OF HEREDITARY DISEASES AND HOW TO TREAT THEM |
|
|
Term
|
Definition
THE AVAERAGE LIFE SPAN IN THE US >BY 20YRS IN TGE 20TH CENTURY
IN WORLD WAR 1 MORE SOLDIERS DIED FROM INFECTIONS RATHER THAN THE WOUNDS THEMSELVES IN WORLD WAR II THE MASS PRODUCTIONS OF ANTIBIOTICS PENICILLIN SAVED THOUSANDS OF LIVES AND WAS SEEN AS A CRITICAL FACTOR IN THE SUCCESS OF THE ALLIED FORCES |
|
|
Term
|
Definition
TO BECOME A PHARMACIST IN THE US AN INDIVIDUAL MUST GRADUATE FROM AN ACCREDITED COLLEGE OF PHARMACY PASS A STATE LISCENSING EXAM AND PERFORM AN INTERNSHIP WORKING UNDERA LISCENCED PHARMACIST
ONCE LICENCED THE PHARMACIST MUST RECEIVE CONTINUING EDU CREDITS TO MAINTAIN THEIR LICENSE
COST OF HEALTH CARE IN THE US 1970-2000>BY OVER 1500%+HAS FURTHER>AN ESTIMATED 48% BETWEEN 2000-2005 TO 2.016TILLION
INCREASING COST OF HEALTH CARE HAS BROUGHT INCREASED EFFORTS TO CONTROL THE COST OF PRESCRIPTON DRUGS ONE ASPECT OF WHICH IS THE USE OF CLOSED FORMULARIES THAT RELY SUBSTANTIALLY ON SUBSTITUTING GENERIC DRUGS IN PLACE OF MORE EXPENSIVE BRANDS |
|
|
Term
| KC-1 COMPUTERIED PHARMACY |
|
Definition
| COMPUTERIZED PHARMACY MANAGEMENT SYSTEMS PUT CUSTOMER PROFILE PRODUCT INVENTORY PRICING AND OTHER ESSENTIAL INFORMATION WITHIN EASY ADDESS ONE RESLUT HAS BEEN THAT PHARMACIES AND PHARMACIST DISPENSE MORE PRESCRIPTIONS AND INFO THAN EVER BEFORE |
|
|
Term
|
Definition
| INDIVIDUALS GIVEN A BASIC LEVEL OF TRAINING TO HELP THEM PERFORM SPECIFIC TASKS |
|
|
Term
| PHARMACISTS RELY UPON THE ASSISTED TRAINED SUPPORT OF |
|
Definition
|
|
Term
|
Definition
| INCLUDE SUCH TASKS AS FILLING PRESCRIPTIONS PACKAGING DOSES PERFORMING INVENTORY CONTROL AND KEEPING RECORDS |
|
|
Term
| MOST PHARM TECHS EMPLOYED IN |
|
Definition
| COMMUNITY PHARMACIES AND HOSPITALS |
|
|
Term
|
Definition
| RECEIVE PRESCRIPTIONS FILL PRESCRIPTIONS USE COMPUTERS DO COMPOUNDING INVENTORY CONTROL ORDERING WORK WITH A TEAM OF HEALTH CARE PROFESSIONALS |
|
|
Term
| PHARMS TECHS SPECIFIC RESPONSIBILITIES AND TASKS |
|
Definition
| DIFFER BY SETTING AND ARE DESCRIBED IN WRITING BY EACH EMPLOYER REFERRED TO AS SCOPE OF PRACTICE |
|
|
Term
| PHARM TECH HAS PERSONAL STANDARDS |
|
Definition
DEPENDABLE
DETAIL ORIENTED
TRUSTWORTHYHEALTH
HYGIENE
APPEARANCE
MATHEMATICS AND PROBLEM SOLVING
LANGUAGE AND TERMINOLOGY
COMPUTER SKILLS
INTERPERSONAL SKILLLS
THERE ARE LEGAL ASPECTS TO MANY OF THESE STANDARDS FAILING TO FOLLOW THEM CAN HURT YOUR JOB PERFORMANCE AND RESULT IN LEGAL VIOLATIONS |
|
|
Term
|
Definition
| TO MAKE AN ACCOUNTING OF ITEMS ON HAND ALSO WITH PEOPLE TO ASSESS CHARECRERISTICS SKILLS QUALITIES ETC |
|
|
Term
|
Definition
| THE REQUIREMENT OF HEALTH CARE PROVIDERS TO KEEP ALL PT INFO PRIVATE AMONG THE PATIENT THE PATIENT INSURER AND THE PROVIDERS DIRECTLY INVOLVED IN THE PT'S CARE |
|
|
Term
|
Definition
| 1990 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT MAKES HEALTH CARE PROVIDERS KEEP ALL FORMS OF RECORDS AND COMMUNICATION KEPT PRIVATE |
|
|
Term
| TRAINING FOR PHARM TECH CAN INCLUDE |
|
Definition
DRUG LAWS
TERMINOLOGY
PRESCRIPTIONS
CALCULATIONS
DRUG ROUTES AND FORMS
DRUG DOSAGE AND ACTIVITY
INFECTION CONTROL
COMPOUNDING
PREPARING IV ADMISTURES
BIOPHARMACEUTICS
DRUG CLASSIFICATIONS
INVENTORY MANAGEMENT
PHARMACY LITERATURE
AND WILL LEARN ON THE JOB AR AN INTERNSHIP |
|
|
Term
|
Definition
| ASHP AMERICAN COCIETY OF HEALTH SYSTEM PHARMACISTS |
|
|
Term
| TRAINING WILL PREPARE YOU TO |
|
Definition
|
|
Term
|
Definition
| MONITOR AND DOCUMENT YOUR COMPETENCY |
|
|
Term
| DEMONSTRATIONS OF COMPETENCY |
|
Definition
| WRITTEN TEST AND PRACTICAL DEMONSTRATIONS ON THE JOB TRAINING INTERNSHIPS |
|
|
Term
|
Definition
| CRITICAL ELEMENT IN MAINTAINING COMPETENCY MAKES JOB MORE EFFECTICE AND MORE INTERESTING IE NEW DRUGS NEW TX ETC |
|
|
Term
|
Definition
| PERFORMANCE REVIEWS COMPLAINTS COMMENTS BY SUPERVISOR AND OTHER APPROP PERSONNEL |
|
|
Term
|
Definition
AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS
7272 WISCONSIN AVE
BETHESDA MD 20814
301-657-3000
ASHP.ORG |
|
|
Term
|
Definition
VALUABLE CAREER STEP SINCE NO FEDERAL STANDARD FOR TRAINING OR COMPETENCY
MUST BE RENEWED EVERY 2 YRS
MARK OF ACHIEVMENT THAT EMPLOYER,COLLEGUES AND OTHERS WILL RECOGNIZE |
|
|
Term
| PHARNMACY TECH CERTIFICATION EXAM PTCE TESTS |
|
Definition
ASSIST THE OHARMACIST IN SERVING PATIENTS(66%)
MAINTAINING MEDICATION AND INVENTORY CONTROL SYSTEMS(22%)
PARTICIPATING IN THE ADMINISTRATION AND MANAGEMENT OF PHARMACY PRACTICE (12%)
IT CONTAINS 100 MULTIPLE CHOICE QUESTIONS TO WHICH THE BEST ANSWER IS CHOSEN
EXAMS LAST 2 HOURS AND AS OD FEB2007 WILL BE ADMINISTERED IN A COMPUTER BASED TESTING ENVIRONMENT
TO TAKE THE EXAM CANIDATES MUST HAVE A HS OR GED BY APP DEADLINE AND NEVER CONVICTED OF A FELONY
TO PASS MUST SCORE 650 OUT OF A POSSIBLE 900 |
|
|
Term
| PHARMACY TECHNICIAN CERTIFICATION BOARD |
|
Definition
1100 15TH STREET NW
SUITE 730
WASHINGTON DC 20005-1707
800 363-8012 PHONE
202 429-7596 FAX
PTCB.ORG |
|
|
Term
|
Definition
| BEING QUALIFIED AND CAPABLE |
|
|
Term
|
Definition
A LEGAL PROOF OR DOCUMENT THAT AN INDIVIDUAL MEETS CERTAIN OBJECTIVE STANDARDS USUALLY PROVIDED BY A NEUTRAL
PROFESSIONAL ORGANIZATION |
|
|
Term
| PHARMACIES LOCATED IN HOSPITALS ARE REQUIRED TO FOLLOW REGULATIONS OF THIS ORGANIZATION |
|
Definition
|
|
Term
OF THE FOLLOWING SCHEDULES OF DRUGS WHICH IS FOR DRUGS WITH NO ACCEPTED MEDICAL USE IN THE US
SCHED 1 SCHED 11 SCHED III SCHED IV |
|
Definition
|
|
Term
OF THE FOLLOWING NEEDLES WHICH IS THE MOST LIKELY TO CAUSE CORING
13G 16G 20G 23G |
|
Definition
|
|
Term
A SOLUTION OF HALPERIDOL (HALDOL)CONTAINS 2MG/ML OF ACTIVE INGREDIENT
HOW MANY GRAMS WOULD BE IN 473ML OF THIS SOLUTION
9.46GM 0.956GM 0.0946GM 0.00946GM |
|
Definition
|
|
Term
YOU HAVE A 70%SOLUTION OF DEXTROSE 1000ML HOW MANY Kg OF DEXTROSE IS IN 400ml OF THIS SOLUTION
280Kg 28Kg 2.8Kg 0.28Kg |
|
Definition
|
|
Term
WHICH IS THE LARGEST CAPSULE SIZE
SIZE 5 SIZE 3 SIZE 1 SIZE 0 |
|
Definition
|
|
Term
|
Definition
PHARMACY TECHS PERFORM ESSENTIAL TASKS THAT DO NOT REQUIRE THE PHARMACIST EXPERTISE
PHARMACY TECH WORK UNDER THE DIRECT SUPERVISION OF A LISCENSED PHARMACISTS WHO IS LEGALLY RESPONSIBLE FOR THEIR PERFORMANCE
THE SPECIFIC RESPONSIBILITIES AND TASKS FOR PHARM TECH DIFFER BY SETTING AND ARE DESCRIBED IN WRITING BY EACH EMPLOYER THROUGH JOB DESCRIPTIONS POLICY AND PROCEDURE MANUALS AND ODTHER DOCUMENTS
HAVING TECHS PERFORM THESE TASKS GIVES THE PHARMACISTS MORE TIME FOR ACTIVITIES
WHICH REQUIRE A GREATER LEVEL OF EXPERITSE SUCH AS CONSULTING WITH PATIENTS
WHAT INDIVIDUALS MAY AND NOT DO IS OFTEN REFERRED TO AS THEIR SCOPE OF PRACTICE
LIKE PHARMACISTS MOST PHARM TECHS ARE EMPLOYED IN COMMUNITY PHARMACIES AND HOSPITALS
HOWEVER THEY ARE ALSO EMPLOYED IN CLINICS HOME CARE LONG TERM CARE MAIL ORDER PRESCRIPTION PHARMACIES AND VARIOUS OTHER SETTINGS
IN VARIOUS HOSPITAL AND OTHER ENVIRONMENTS THERE ARE SPECIALIZED TECH JOBS WHICH REQUIRE MORE ADVANCED SKILLS DEVELOPED FORM ADDITIONAL EDUCATION TRAINING AND EXPERIENCE |
|
|
Term
|
Definition
PHARMACY TECHS ARE ENTRUSTED WITH CONFIDENTIAL PATIENT INFO DANGEROUS SUBTANCES AND PERISHABLE PRODUCTS
DRUGS WHETHER PRESCIPTION OR OVER THE COUNTER CAN BE DANGEROUS IF MISUSED AND MISTAKES BY PHARM TECH CAN BE LIFE THREATENING
PHARM TECH ROUTINELY PERFORM MATHMATICAL CALC IN FILLING PRESCRIPTIONS AND OTHER ACTIVITIES
PHARMACY TECH MUST LEARN SPECIFIC PHARMACEUTICAL TERMNINOLOGY THAT WILL BE USED ON THE JOB
PHARM TECH MUST BE ABLE TO COMMUNICATE COOPERATE AND WORK EFFECTIVELY WITH OTHERS |
|
|
Term
| KC-2 TRAINING AND COMPETENCY |
|
Definition
| STANDARDS FOR PHARM TECH TRAINING OR COMPETENCY ARE ESTABLISHED BY THE STATE BOARDS OF PHARMACY REGULATIONS VARY CONSIDERABLY BUT AS OF 2006 28 STATES REQUIRED SOME FORM OF TECH TRAINING |
|
|
Term
|
Definition
ALTHOUGH CERTIFICATION IS MAINLY VOLUNTARY 25 STATES NOW RECOGNIZE THE PTCB CERTIFICATION AND SOME ARE NOW REQUIRING THAT PHARM TECH EARN CERTIFICATION BEFORE BECOMING EMPLOYED BY TAKING THE PTCE OR OTHER EXAM WHICH MAY BE APPROVED BY THEIR STATE BOARD
THE CPhT DESIGNATION CERTIFIED PHARM TECH IS GOOD FOR TWO YEARS IT VERIFIES AN INDIVIDUALS COMPETENCE AS A TECH AND INDICATES A HIGH LEVE OF KNOWLEDGE AND SKILL |
|
|
Term
|
Definition
| PROTECTED HEALTH INFORMATION |
|
|
Term
| AFTER PASSING THE NATIONAL PHARMACY TECH CERT EXAM THEY MAY USE______ AFTER THEIR NAME |
|
Definition
|
|
Term
| CPhT NEED ____ HOURS OF CONTINUING EDUCATION EVERY __ YEARS |
|
Definition
|
|
Term
CONTINUING EDUCATION MUST CONTAIN ___ HR
IN PHARM LAW EVERY __YEARS |
|
Definition
|
|
Term
| _____ IS THE LEADING ASSOC FOR PHARMACISTS PRACTICING IN HOSPITALS AND OTHER HEALTH CARE SYSTEMS |
|
Definition
|
|
Term
| IN THE US AN ORGANIZATION THA PERFORMS PHARM TECH CERT IS THE |
|
Definition
|
|
Term
| FOOD AND DRUG ACT OF 1906 |
|
Definition
| PROHIBITED INTERSTATE COMMERCE IN ADULTERATED OR MISBRANDED FOOD DRINKS AND DRUGS GOVERNMENT PREAPPROVAL OF DRUGS IS REQUIRED |
|
|
Term
FOOD DRUG AND INSECTICIDE ADMINISTRATION
1927 |
|
Definition
| THE LAW INFORCEMENT AGENCY IS FORMED THT WOULD BE RENAMED IN 1930 AS THE FOOD DRUG ADMINISTRATION(FDA) |
|
|
Term
| 1950 ALBERTY FOOD PRODUCTS VS US |
|
Definition
| THE US STATES COURT OF APPEALS RULES THT THE PURPOSE FOR WHICH A DRUG IS TO BE USED MUST BE INCLUDED ON THE LABEL |
|
|
Term
|
Definition
| IN RESPONSE TO GROWING ADDICTION TO OPIEATES AND COCAINE CONTAINING MEDICINES THE HARRISON TAX ACT ESTABLISHED THT MANUFACTURERS PHARMACISTS IMPORTERS AND PHYSICIANS PRESCRIBING NARCOTICS SHOULD BE LICENSED AND REQUIRED TO PAY A TAX |
|
|
Term
| 1938 FOOD DRUG AND COSMETIC (FDC)ACT |
|
Definition
| IN RESPONSE TO THE FATAL POISONING OF 107 PEOPLE PRIMARILY CHILDREN BY AN UNTESTED SULFANILAMIDE CONCOCTION THIS COMPREHENSIVE LAW REQUIRES NEW DRUGS BE SHOWN TO BE SAFE BEFORE MARKETING |
|
|
Term
|
Definition
NEW SLEEPING PILL CONTAINING DRUG THALDOMIDE FOUND TO CAUSE SEVERE BIRTH DEFECTS ALTHOUGH THIS DRUG HAD NOT BEEN APPROVED IN US YET SO CASES IN US WERE FAR LESS THAN EUROPE IT CAUSES A
PUBLIC DEMAND FOR TIGHTER DRUG REGULATIONS IN THE US RESULTING IN THE KEFAUVER-HARRIS AMENDMENT DRUGS WOULD HAVE TO BE SHOWN TO BE SAFE AND EFFECTIVE BEFORE THEY COULD BE MARKETED IN THE US THALDOMIDE NOW USED TO TX MULTIPLE MYELOMA BUT STILL HAS WARNNGS ON IT TO REMIND OF THE RISKS AND HE ACTIONS THEY MUST TAKE WHILE BEING TX WITH IT |
|
|
Term
| 1951 DURHAM-HUMPREY AMENDMENT |
|
Definition
| THIS LAW DEFINES WHAT DRUGS REQUIRE A PRESCRIPTION BY A LICENSED PRACTITIONER AND REQUIRES THEM TO INCLUDE THIS LEGEND ON THE LABEL-->CAUTION FEDERAL LAW PROHIBITS DESPENSING WITHOUT A PRESCRIPTION OR THE MORE RECENT RX ONLY |
|
|
Term
|
Definition
| ANY DRUG WHICH REQUIRES A PRESCRIPTION AND EITHER OF THESE LEGENDS ON THE LABEL--CAUTION FEDERAL LAW PROHIBITS DISPENSING WITHOUT A PRESCRIPTION OR RX ONLY |
|
|
Term
| 1962 KEFHAUVER HARRIS AMENDMENT |
|
Definition
| REQUIRES DRUG MANUFACTERS TO PROVIDE PROOF OF BOTH SAFETY AND EFFECTIVENESS BEFORE MARKETING THE DRUG |
|
|
Term
| 1966 FAIR PACKAGING AND LABELING ACT |
|
Definition
| THIS REQUIRES ALL CONSUMER PRODUCTS IN INTERSTATE COMMERCE TO BE HONESTLY AND INFORMATIVELY LABELED |
|
|
Term
| 1970 CONTROLLED SUBSTANCES(CSA) |
|
Definition
| THE CSA CLASSIFIES FIVE LEVELS OF DRUGS(CONTROLLED SUBSTANCES)THAT HAVE POTENTIAL FOR ABUSE AND THEREFORE RESTRICTS THEIR DISTRIBUTION THE DRUG ENFORCEMENT ADMINISTRATION (DEA)AS A DIVISION IF THE JUSTICE DEPARTMENT WAS ESTABLLISHED BY THE CSA AND ENFORCES ITS REGULATIONS |
|
|
Term
| 1976 MEDICAL DEVICE AMENDMENT |
|
Definition
| REQUIRES PREMARKET APPROVAL FOR SAFETY AND EFFECTIVENESS OF LIFESUSTANING AND LIFE SUPPORTING MEDICAL DEVICES |
|
|
Term
| 1987 PRESCRIPTION DRUG MARKETING ACT |
|
Definition
| RESTRICTS DISTRIBUTION OF PRESCRIPTION DRUGS TO LEGITIMATE COMMERCIAL CHANNELS AND REQUIRES DRUG WHOLESALERS TO BE LICENSED BY THE STATES |
|
|
Term
| 1990 OMNIBUS BUDGET RECONCILIATION ACT (OBRA) |
|
Definition
| AMONG OTHER THINGS THIS ACT REQUIRES PHARMACISTS TO OFFER COUNSELING TO MEDICAID PTS REGARDING MEDS |
|
|
Term
| 1990 ANABOLIC STEROID CONTROL ACT |
|
Definition
| THIS ACT WAS PASSED TO ADDRESS THE ABUSE OF STEROIDS BY ATHLETES AND EXPECIALLY YOUNGSTERS AND TEENAGERS |
|
|
Term
| 1970 POISON PREVENTION PACKAGING ACT |
|
Definition
| REQUIRES CHILDPROOF PACKAGING ON ALL CONTROLLED AND MOST PRESCRIPTION DRUGS DISPENSED BY PHARMACIES NON-CHILD PROOF CONTAINERS MAY ONLY BE USED IF THE PRESCRIBER OR PATIENT REQUESTS ONE |
|
|
Term
|
Definition
| PROVIDES INCENTIVES TO PROMOTE RESEARCH APPROVAL AND MARKETING OF DRUGS NEEDED FOR THE TREATMENT OF RARE DISEASES |
|
|
Term
| 1984 DRUG PRICE COMPETITION AND PATENT TERM RESTORATION ACT(HATCH-WAXMAN) |
|
Definition
| THIS ACT ALLOWED FOR BOTH THE EXTENSINO OF DRUG PATENT TERMS AND QUICKER INTRODUCTION OF LOWER COST GENERIC DRUGS |
|
|
Term
| 1996 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT |
|
Definition
| DEFINES SCOPE OF HEALTH INFOTHAT MAY AND MAY NOT BE SHARED AMONG HEALTH CARE PROVIDERS WITHOUT PT CONSENT BROAD AND STRICT REGULATIONS TO PROTECT PT RIGHT TO PRIVACY ALL COVERED ENTITIES-MEANING ANY HEALTH CARE PROVDERS USING ELECTRONIC CLAIMS TRANSMISSIONS BILLING OR OTHER ELECTRONIC TRANSFEROF PT INFO WERE REQUIRED TO BE COMPLIANT BY 4-4-2003 GOVERNS INCLUDING ELECTRONICALLY ON PAPER OR ORALLY |
|
|
Term
| FDA CENTER FOR DRUG EVALUATION AND RESEARCH |
|
Definition
| PROVIDES INDEX DRUG SPECIFIC INFO WITH PT CONSUMER AND HEALTHCARE PROFESSIONAL INFO SHEETS INCLUDING FDA ALERTS ALSO WORKS WITH DRUG MANUFACTURERES TO DEVELOP RISK MANAGEMENT PROGRAMS FOR DRUGS WITH FDA ALERTS SUCH AS THE IPLEDGE PROGRAM FOR ACCUTANE HEALTH CARE PROFESSIONALS WHOLESALERS AND PHARMACIES AND PATIENTS MUST REGISTER IN THE IPLEDGE PROGRAM TO PRESRIBE DISTRIBUTE FILL PRESCRIPTIONS FOR OR USE ACCUTANE |
|
|
Term
| ALL NEW DRUGS WHETHER MADE DOMESTICALLY OR IMPORTED REQUIRE FDA APPROVAL BEFORE |
|
Definition
| CAN BE MARKETED IN THE US |
|
|
Term
| BEFORE A NEW DRUG CAN BE APPPROVED IT MUST (2) |
|
Definition
SHOWN TO BE SAFE AND EFFECTIVE
ITS BENEFITS SUBSTANTIALLY OUTWEIGH ITS RISKS |
|
|
Term
|
Definition
| TESTING THE DRUG ON PEOPLE |
|
|
Term
|
Definition
| LAB TESTING FIRST THEN ANIMAL TESTING BEFORE HUMAN USUALLY MORE THAN ONE SPECIES IS TESTED ONLY A FRACTION OF DRUGS TESTED ON ANIMALS ARE EVER TESTED ON HUMANS |
|
|
Term
|
Definition
| INACTIVE SUBSTANCES VALUABLE USE TESTING PT IN TRIALS MUST BE AWARE AND AGREE THAT THEY COULD GET EITHER AND THAT THEY UT/WILL BE OFFERED AN EFFECTIVE TX IF ONE IS AVAILABLE |
|
|
Term
|
Definition
| INACTIVE SUBSTANCE GIVEN IN PLACE OF A MED |
|
|
Term
|
Definition
| HAVING TO DO WITH THE TX OF CHILDREN |
|
|
Term
|
Definition
| CHILDREN NOT INCLUDED IN TRIALS UNTIL A DRUG HAS BEEN FULLY TESTED ON ADULTS THOSE NOT TESTED ON CHILDREN GENERALLY HAVE A STATEMENT ON THE LABEL THAT THEIR SAFETY AND EFFECTIVENESS HAS NOT BEEN ESTABLISHED FOR CHILDREN SOME DRUGS HOWEVER MAY CARRY LABEL INFO FOR PEDS BASED ON STUDIES OF ADULTS AND OTHER PEDS TX INFO AOO DRUGS MUST HAVE PEDS DOSING AND SAFETY INFO ON THEIR LABELS IF THE DRUG HAS POTENTIAL USE OF PEDS PTS |
|
|
Term
| PEDIATRIC LABELING RULE 1994 |
|
Definition
| MANDATES THAT ALL DRUGS HAVE PEDS DOSING AND SAFETY INFO ON THEIR LABELS IF THE DRUG HAS POTENTIAL USE FOR PEDS PTS |
|
|
Term
| TESTING PHASES IN HUMANS(3) |
|
Definition
PHASE 1 20-100 PTS SEVERAL MONTHS PURPOSE MAINLY SAFETY
PHASE 2 UPTO SEVERAL HUNDRED PTS SEVERAL MONTHS TO SEVERAL YEARS PURPOSE SHORT TERM SAFETY BUT MAINLY EFFECTIVENESS
PHASE 3 SEVERAL HUNDRED TO SEVERAL THOUSAND PTS ONE TO FOUR YEARS PURPOSE SAFETY DOSAGE AND EFFECTIVENESS
ONLY ABOUT 25% OF DRUGS TESTED IN PHASE 1 SUCESSFULLY COMPLETE PHASE 3 AND ARE APPROVED FOR MARKETING ONCE A DRUG BECOMES AVAILABLE TO THE PUBLIC ADDITIONAL INFO IS COLLECTED ABOUT ITS SAFETY EFFICACY AND USES AND THIS IS SOMETIMES CALLED PHASE 4 |
|
|
Term
|
Definition
| In pharmacology, efficacy, refers to the maximum response achievable from a drug. It is often described by the parameter Emax.[1] Intrinsic activity is a relative term which describes the efficacy relative to a drug which has the highest observed efficacy. Effectiveness refers to the ability of a drug to produce a beneficial effect. A distinction is made between 'method' effectiveness which describes the effect achievable if the drug was taken as prescribed and 'use' effectiveness which is the effect obtained under typical use circumstances when adherence is not 100%. The widely used 'intention to treat' method of analysing clinical trials provides estimates of 'use' effectiveness which are typically biased compared with 'method' effectiveness. |
|
|
Term
| DURING THE TRIAL PHASE A PROPOSED NEW DRUG IS CALLED |
|
Definition
| INVESTIGATIONAL NEW DRUG(IND) |
|
|
Term
|
Definition
| COMPARING THE EFFECT OF A PROPOSED DRUG ON ONE GROUP OF PATIENTS WITH THE EFFECT OF A DIFFERENT TX ON OTHER PTS |
|
|
Term
| PATIENTS IN A TRIAL ARE ALWASY________TO THE TX |
|
Definition
| BLIND(IN A DOUBLE BLIND BOTH PT AND DR DONT KNOW WHICH PTS HAVE GOTTEN REAL DRUG AND WHICH GOT PLACEBO MEDICAL RESULTS ALONE DETERMINE THE DRUGS EFFECTIVENSS AND SAFETY |
|
|
Term
| MEDICAL DEVICES OTHER THAN DRUGS |
|
Definition
| MEDICAL DEVICES AND BIOLOGICAL PRODUCTS SUCH AS INSULIN AND VACCINES MUST ALSO MEET FDA TESTING AND APPROVAL REQUIREMENTS THE CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH) IS RESPONSIBLE FOR THE DEVICES. THE CENTER FOR BIOLOGICS EVALUATION AND RESERCH(CBER)IS RESPONSIBLE FOR BIOLOGICAL PRODUCTS BEING MADE FROM LIVING ORGANISM |
|
|
Term
| A PATENT FOR A NEW DRUG GIVES ITS MANUFACTURER |
|
Definition
| EXCLUSIVE RIGHTS TO MARKET THE DRUG FOR A SPECIFIC PERIOD OF TIME UNDER A BRAND NAME |
|
|
Term
| ONCE A PATENT FOR A DRUG EXPIRES |
|
Definition
| OTHER MANUFACTURERS MAY COPY THE DRUG AND RELEASE IT UNDER ITS PHARMACEUTICAL OR GENERIC NAME |
|
|
Term
| GENERIC DRUGS MUST BE _________EQUIVALENT TO THE BRAND DRUG AND ALSO _________EQUIVALENT |
|
Definition
PHARMACEUTICAL, THERAPEUTIC
PHARMACEUTICALLY EQUIVALENT=HAS SAME ACTIVE INGREDIENTS DOSAGE FORM ROUTE AND STRENGTH
THERAPEUTICALLY EQUIVALENT THAT THE BODYS USE OF THE DRUG IS THE SAME MEASURED BY THE RATE AND EXTENT TO WHICH THE ACTIVE INGREDIENTS ARE ABSORBED INTO THE BLOODSTREAM |
|
|
Term
| EVALUATIONS OF GENERIC DRUG PRODUCTS CAN BE FOUND IN THE |
|
Definition
|
|
Term
| OVER THE COUNTER DRUGS(OTC) ARE DRUGS THAT DO NOT REQUIRE |
|
Definition
|
|
Term
|
Definition
| DIFFERENT LABELS WITH DIFFERENT REQUIREMENTS SUCH AS OTC WHICH HAVE LABELS AND PACKAGING DESIGNED TO HELP THE CONSUMER USE THEM OR PRESCIPTION DRUGS WHICH DO NOT REQUIRE INSTRUCTINOS ON THE LABELS AS THEY ARE REQUIRED TO BE GIVEN BY THE PRESCRIBER AND IN MANY CASES IMPORTANT INFO TOO MUCH FOR A LABEL AND IS GIVEN IN THE FORM OF AN INSERT AND OR AN BROCHURE |
|
|
Term
| FEDERAL LAW REQUIRES THAT DRUG AND OR CONTAINER NOT BE ________IMITATIVE OF ONE ANOTHER SO THAT THE CONSUMER WILL BE MISLED |
|
Definition
IMITATIVE
HOWEVER MANY ARE BY PACKAGING AND OR SOUND(LOOK ALIKE SOUND ALIKE)SO PAY CLOSE ATTENTION TO DETAIL WRONG DRUG CAN HAVE VERY SERIOUS CONSEQUENCES |
|
|
Term
|
Definition
INFO ON PHARMACEUTICAL AND THERAPEUTIC EQUIVALENT
(ALSO SEE CH 3 AND CH 10 OF PHARM TECH WORKBK AND CERTIF REVIEW 3RD EDITION) |
|
|
Term
| PHARMACEUTICAL EQUIVALENT |
|
Definition
| DRUG PRODUCTS THAT CONTIAN IDENTICAL AMOUNTS OF THE SAME ACTIVE INGREDIENTS IN THE SAME DOSAGE FORM |
|
|
Term
|
Definition
| PHARMACEUTICAL EQUIVALENTS THAT PRODUCE THE SAME EFFECTS IN PATIENTS |
|
|
Term
|
Definition
| IMPORTANT ASSOC INFO NOT ON THE LABEL OF THE DRUG ITSELF BUT PROVIDED WITH PRODUCT IN THE FORM OF A INSERT,BROCHURE OR OTHER DOCUMENT |
|
|
Term
OTC DO NOT REQUIRE A __________
AND LIST 5 THINGS THAT SHOULD BE ON THE
LABEL OF OTC MEDS |
|
Definition
PRESCRIPTION (HOWEVER SOMETIMES ONE IS WRITTEN FOR THEM FOR INSURANCE OR OTHER REASONS AND SINCE THEY ARE NOT WITHOUT RISKS A PT REQUESTING INFO ON THEM SHOULD BE REFERRED TO THE PHARMACIST CAN BE OTHER ISSUES LIKE DRUG INTERACTIONS WITH OTHER DRUGS
THE FOLLOWING SHOULD BE CONTAINED ON THE LABEL OF OTC
PRODUCT
NAME AND ADDRESS OF MANUFACTURER OR DISTRIBUTOR
LIST OF ALL ACTIVE AND OTHER INGREDEINTS
AMOUNT OF CONTENTS
ADEQUATE WARNINGS
ADEQUATE DIRECTIONS FOR USE |
|
|
Term
| SOME OTC DRUGS THAT DO NOT REQUIRE A PRESCRIPTION ARE KEPT _______THE_______ |
|
Definition
| BEHIND,COUNTER(ie ephedrine,pseudoephedrine) |
|
|
Term
| THE COMBAT METHAMPHETAMINE EPIDEMIC ACT |
|
Definition
SETS DAILY AND MONTHLY LIMITS TO AN INDIVIDUAL THAT CONTAIN EPHEDRINE PSEUDOEPHEDRINE AND PHENYLPROPANOLAMINE(PHENYLPROPANOLAMINE NO LONGER IN OTC)
3.6GPER DAY AND 7.5G MONTH
PHARMACY MUST GET AND KEEP THE FOLLOWING INFO FOR 2 YEARS
PRODUCT NAME
QUANITY SOLD
NAME AND ADDRESS OF PURCHASER
DATE AND TIME OF THE SALE
PROOF OF IDENTIFICATION
SIGNATURE OF THE PURCHASER |
|
|
Term
|
Definition
DRUGS THAT CONTAIN INGREDIENTS THAT MAY BE HABIT FORMING BUT CAN BE SOLD BY A PHARMACIST WITHOUT OF PRESCRIPTION TO PERSONS AT LEAST 18YRS OF AGE IE COUGH SYRUP WITH CODEINE (BY FED STATE OR LOCAL LAW)
DISPENSING ONLY BY A PHARMACIST TECH MAY COMPLETE THE TRANSACTION AFTER PHARMACIST APPROVED AND DOCUMENTS DISPENSING
LIMITS FOR HOW MANY ODSAGE UNITS CAN BE SOLD INANY GIVEN 48HR
PURCHASERS AT LEASE 18YO AND THOSE NOT KNOWN TO PHARMACIST MUCH PROVED ID
BOUND RECORD BOOK CONTAINIG THE NAME AND ADDRESS OF THE PURCHASER NAME AND QUANITY OF THE EXEMPT NARCOTIC THE DATE OF THE PURCHASE NAME OR INITIALS OF THE PHARMACIST WHO DISPENSES MAINTAINED |
|
|
Term
|
Definition
PLAN B IS A DRUG INDICATED FOR EMERG CONTRACEPTION(EC) HAS DUAL MARKETING STATUS AND THAT MEAMS IT HAS BOTH PRESCRIPTION AND OTC DRUG STATUS
PRESCRIPTION IS REQUIRED TO 17YOAND UNDER
OTC FOR 18YO OR OLDER PRESCRTIBED BY A PHARMACIST
A FEW STATES GIVE PHARMACISTS AUTHORITY TO PRESCRIBE TO 17 AND UNDER |
|
|
Term
|
Definition
| MEDICATIONS WITH HABIT FORMING INGREDIENTS THAT COULD BE DISPENSED BY A PHARMACIST WITHOUT A SCRIPT TO PERSONS AT LEAST 18YO |
|
|
Term
|
Definition
| STATUS MEDS LIKE PLAN B THAT ARE CLASSIFIED AS BOTH SCRIPT AND OTC |
|
|
Term
|
Definition
PACKAGE INSERT OR PRESCRIBING INFO
INCLUDES
CLINICAL PHARMACOLOGY
INDICATIONS AND USAGE
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
ADVERSE REACTIONS
DRUG ABUSE AND DEPENDENCE
DOSAGE
PACKAGING
DESIGNED TO INFORM BOTH THE PRESCRIBER
AND DISPENSER |
|
|
Term
|
Definition
INCLUDES
GENERIC NAME
BRAND NAME
NDC NUMBER
MANUFACTURER NAME AND ADDRESS
ACTIVE INGREDIENTS AND THEIR STRENGTH
TYPE OF DISPENSING CONTAINER REQUIRED
STORAGE REQUIREMENTS (all drugs unless requested otherwise are to be put in a childproof cap)
LOT NUMBER AND EXP DATE
HABIT FORMING INGREDIENT IF APPLICABLE
PACKAGE QUANITY
LEGEND STATEMENT
DRUG FORM
CONTROLLED SUBSTANCE MARK |
|
|
Term
NDC(WHAT IS IT)
IDENTIFICATION NUMBER(3 PARTS AND WHAT THEY STAND FOR) |
|
Definition
NATIONAL DRUG CODE NUMBERS
ASSIGNED BY THE DRUG MANUFACTERER TO A DRUG PRODUCT EACH NDC HAS 3 SETS OF NUMBERS
FIRST SET MANUFACTURER
SECOND SET MEDICATION(STRENGH AND DOSAGE FORM)
THIRD SET PACKAGE SIZE
DEPENDING ON WHETHER THIS IS A NEWER OR OLDER DRUG THE 1ST SET OF NUMBERS COULD HAVE 4 OR 5 DIGITS AND THE SECOND SET OF NUMBERS COULD HAVE 3 OR 4 DIGITS THE LAST SET ALWAYS HAS TWO DIGITS |
|
|
Term
|
Definition
| THE MARK (CH-CV) WHICH INDICATES THE CONTROL CATEGORY OF A DRUG WITH A POTENTIAL FOR ABUSE |
|
|
Term
DISPENSED PRESCRIPTION DRUG LABEL
REQUIRMENTS MINIMAL
STATED IN PRESCRIPTION |
|
Definition
MINIMUM
NAME AND ADDRESS OF DISPENSER
PRESCRIPTION SERIAL NUMBER
DATE OF PRESCRIPTION OR FILLING
EXP DATE
NAME OF PRESCRIBER
AND ANY STATED IN THE SCRIPT
NAME OF PATIENTS
DIRECTIONS OF USE
CAUTIONARY STATEMENTS
CERTIAN DRUGS HAVE GREATER REQUIREMENTS AND MANY STATES IMPOSE GREATER REQUIREMENTS
(LOOK UP FOR VA) |
|
|
Term
| TYPICAL ELEMENTS ON A PRESCRIPTION LABEL |
|
Definition
MANE AND ADDRESS OF THE DISPENSER
DATE FILLED
PRESCRIPTION NUMBER
PATIENT NAME
DIRECTIONS FOR USE
NAME QUANITY STRENGTH MANUFACTURER AND DOSAGE FORM
EXP DATE
PRESCRIBER
REFILLS AVAILABLE
INITIALS OF THE DISPENSING PHARMNACIST |
|
|
Term
| GOVERNMENT TIGHTLY CONTROLS USE OF DRUGS THAT CAN BE EASILY ________ |
|
Definition
|
|
Term
|
Definition
SCHEDULE 1-EACH DRUG HAS A HIGH POTENTIAL FOR ABUSE AND NOACCEPTED MEDICAL USE IN THE US IT MAY NOT BE PRESCRIBED HEROIN VARIOUS OPIUM DERIVATIVES AND HALLUCINOGENS SUBSTANCES ARE INCLUDED IN THIS SCHEDULE
SCHEDULE 2 EACH DRUG HAS A HIGH POTENTIAL FOR ABUSE AND MAY LEAD TO PHYSICAL OR PSYCHOLOGICAL DEPENDENCE BUT ALSO HAS A CURRENTLY ACCEPTED MECICAL USE IN THE US AMPHETAMINES OPIUM COCAINE METHADONE AND VARIOUS OPIATES ARE INCLUDED IN THIS SCHEDULE
SCHEDULE 3 EACH DRUGS POTENTIAL FOR ABUSE IS LESS THAN THOSE IN SCHED 1 OR 2 AND THERE IS A CURRENTLY ACCEPTED MEDICAL USE IN THE US BUT ABUSE MANY LEAD TO MODERATE OR LOW PHYSICAL DEPENDENCE OR HIGH PHYCHOLOGICAL DEPENDENCE ANABOLIC STEROIDS AND VARIOUS COMPOUNDS CONTAINING LIMITED QUANITIES OF NARCOTIC SUBSTANCES SUCH AS CODEINE ARE INCLUDED IN THIS SCHEDULE
SCHEDULE 4 EACH DRUG HAS A LOW POTENTIAL FOR ABUSE RELATIVE TO SCHED 3 AND THERE IS A CURRENTLY ACCEPTED MEDICAL USE IN THE US BUT ABUSE MAY LEAD TO LIMITED PHYSICAL DEPENDENCE OR PSYCHOLOGICAL DEPENDENCE PHENOBARBITAL THE SEDATIVE CHLORAL HYDRATE AND THE ANESTHETIC METHOHEXITAL ARE INCLUDED IN THIS GROUP
SHEDULE 5 EACH DRUG HAS A LOW POTENTIAL TO ABUSE REALATIVE TO SCHED 4 AND THERE IS A CURRENTLY ACCEPTED MEDICAL USE IN THE US BUT ABUSE MAY LEAD TO LIMITED PHYSICAL OR PHYCHOLOGICAL DEPENDENCE COMPOUNDS CONTAINING LIMLITED AMOUNTS OF A NARCOTIC SUCH AS CODEINE ARE INCLUDED IN THIS GROUP
(THESE SCHEDULES ARE REVISED PERIODICALLY) |
|
|
Term
|
Definition
| MANUFACTERS MUST CLEARLY LABEL CONTROLLED DRUGS WITH THEIR CONTROL CLASSIFICATION |
|
|
Term
| RECORD KEEPING CONTROLLED DRUGS |
|
Definition
DISTRIBUTORS REQUIRED MAINTAIN ACCURATE RECORDS ALL CONTROLLED SUBSTANCE ACTIVITY IE INVENTORY AND DRUGS DISPERSMENT SCHED2 MUST BE KEPT 7YRS AND ALLOTHER 2YRS UNLESS STATE REQUIREMENTS ARE DIFFERENT SCHED2 PRESP
RECORDS MUST ALSO BE KEPT SEPERATE FROM NONCONTROLLED DRUG RECORDS IN SOME CASES THEY MAY BE KEPT WITH OTHER CONTROLLED RECORDS |
|
|
Term
| SECURITY FOR CONTROLLLED DRUGS |
|
Definition
GENERALLY STORED LOCKED TAMPERPROOF NARCOTICS CABINET SECURED TO WALL/FLOOR
FOR SCHED 2
SCHED 3,4,5 MAY BE KEPT OPENLY ON STORAGE SHELVES |
|
|
Term
|
Definition
| BY LAW BOTH PRESCRIBER AND DISPENSER HAVE JOINT MEDICAL RESPONSIBILITY FOR THE LEGIMATE PURPOSE OF THE PRESCRIPTION PRIMARILY INTENDED TO ENSURE THAT CONTROLLED SUBSTANCES NOT BE PRESCRIBED TOINAPP REASONS |
|
|
Term
|
Definition
ALL PRESCRIBERS CONTOLLED SUBSTANCES
MUST BE AUTHORIZED BY DEA AND HAVE A DEA NUMBER USED ON ALL CONTROLLED DRUG PRESCRIPTIONS |
|
|
Term
|
Definition
| 5 GROUPS DRUGS IDENTIFIED BY 1970 CONTROLLED SUBSTANCE ACT(CSA) AS HAVING THE POTENTIAL ABUSE AND WHOSE DISTRIBUTION IS THEREFORE STRICTLY CONTROLLED BY FIVE CONTROL SCHEDULES SET FORTH IN THE CSA |
|
|
Term
| 1970 CONTROLLED SUBSTANCE ACT |
|
Definition
| FIVE GROUPS OF DRUGS IDENTIFIED HAVING THE POTENTIAL FOR ABUSE AND WHOSE DISTRIBUTION IS THEREFORE STRICTLY CONTROLLED BY FIVE CONTROL SCHEDULES SET FORTH IN THE CSA |
|
|
Term
|
Definition
USED TO ORDER C1 AND C2 SUBSTANCES MUST BE FILLED OUT IN PEN TYPEWRITER OR INDELIBLE PENCIL AND BE SIGNED BY AN AUTHORIED PERSON IN TRIPLICATE
COPY 1 RETAINED BY THE SUPPLIER
COPY2 FORWARDED TO THE DEA
COPY 3 RETAINED BY THE PURCHASER
PURCHASER MUST RECORD THE NUMBER
OF CONTAINERS RECEIVED AND THE
DATES THE DRUGS WERE RECEIVED
EACH FORM HAS ITS OWN SERIAL NO ISSUED WHEN REQUESTED AND ALL MUST BE KEPT ON HAND FOR 7YRS EVEN IF THEY ARE FILLED OUT INCORRECTLY THIS FORM CAN BE REQUESTED ONLINE FROM DEADIVERSION.USDOJ.GOV/DRUGREG/INDEX.HTML
NOTE THAT C3 AN C4 DONT REQUIRE FEDERAL ORDER FORMS BECZUSE OF THEIR LOWER POTENTIAL FOR ABUSE |
|
|
Term
| CONTROLLED SUBSTANCE PRESCRIPTIONS |
|
Definition
SCHED 2-MUST BE SIGNED BY PRESCRIBER
MANY STATES REQUIRE A TIME LIMIT TO BF FILLED
QUANITIES ARE LIMITED
GENERALLY NO REFILLS
SCHED 3-4 LESS STRINGENT
FAXED PRESCRIPTIONS ALLOWED
MAY BE REFILLED UP TO 5X WITHIN A 6MO PERIOD
HOWEVER STATE AND OTHER REGULATIONS MAY BE STRICTER THAN FDERAL REQUIREMENTS
MUST KNOW THE REQUIREMENTS FOR YOUR SETTING |
|
|
Term
| DEA NUMBER FORMULA NUMBER REQUIRED BY LAW |
|
Definition
MUST ADD THE SUM OF THE FIRST THIRD AND FIFTH DIGITS TO TWICE THE SUM OF THE SECOND FOURTH AND SIXTH DIGITS AND ITS LAST NUMBER SHOULD BE THE SAME AS THAT ON THE DEA PRESCRIPTION NUMBER
AB1234563 (1+3+5) + 2(2+4+6) =33 |
|
|
Term
| DEA NUMBER 222 MOST COMMON USED BUT THERE ARE MANY OTHER SPECIFIC FORMS USED BY MANUFACTERS DISTRIBUTOR AND DISPENSER OF CONTROLLED SUBSTANCES |
|
Definition
LISTS OF ALL DEA FORMS AND SAMPLES OF MOST COMMON USED ONES FOUND ONLINE
AT DEADIVERSION.USDOJ.GOV/DRUG REG/INDEX.HTML |
|
|
Term
FDA APPROVAL PROCESS THOROUGH BUT IMPOSSIBLE TO FULLY PROVE DRUG SAFE USE
SEVERAL OPTIONS IF DETERMINES A DRUG PRESENTS A RISK FOR ILLNESS INJIRY OR GROSS CONSUMER DECEPTION (2) |
|
Definition
|
|
Term
|
Definition
| COURT ORDER PREVENTING A SPECIFIC ACTION SUCH AS THE DISTRIBUTION OF A POTENTIALLY DANGEROUS DRUG |
|
|
Term
|
Definition
| ACTION TAKEN TO REMOVE A DRUG FROM THE MARKET AND HAVE IT RETURNED TO THE MANUFACTER |
|
|
Term
|
Definition
| AN UNINTENDED SIDE EFFECT OF A MEDICATION THAT IS NEGATIVE OR IN SOME WAY INJURIOUS TO A PATIENTS HEALTH |
|
|
Term
| RECALLS ARE VOLUNTARY HOWEVER IT IS SUBSTANTIAL PRESSURE ON THE COMPANY AND USUALLY NOT FAVORABLE FOR THE COMPANY TO REFUSE TO DO SO DAMAGING TO COMPANY AND FDA COULD TAKE CO TO COURT AND CRIMINAL CHARGES COULD BE FILED IN CASE OF CERTAIN CASES SUCH AS INFANT FORMULA OR DEVICES WHICH IMPOSE A SERIOUS HEALTH HAZARD FDA RECALL CAN BE MANDATORY AND OF COURSE A COMPANY CAN RECALL A PRODUCT ON ITS OWN AS WELL |
|
Definition
|
|
Term
| RECALL CLASSIFICATIONS (3) |
|
Definition
CLASS I WHEN THERE IS A STRONG LIKELIHOOD THAT THE PRODUCT WILL CAUSE
SERIOUS ADVERSE EFFECTS OR DEATH
CLASS II WHERE A PRODUCT MAY CAUSE SERIOUS BUT REVERSIBLE TEMPORARY ADVERSE EFFECTS OR IN WHICH THERE IS LITTLE LIKELIHOOD OF SERIOUS ADVERSE EFFECTS
CLASS III WHERE A PRODUCT IS NOT LIKELY TO CAUSE ADVERSE EFFECTS |
|
|
Term
|
Definition
REPORTS OF ADVERSE EFFECTS-->FDA RECEIVES ENOUGH REPORTS ADVERSE EFFECTS OR MISBRANDING DECIDES PRODUCT THREAT TO PUBLIC HEALTH CONTACTS MANUFACTURER AND RECOMMENDS A RECALL
MANUFACTURER AGREES TO RECALL--->ESTABLISHES A RECALL STRATEGY W/FDA THAT ADDRESSES THE DEPTH OF RECALL EXTENT OF PUBLIC WARNINGS MEANS CHECKING EFFECTIVENESS RECALL
DEPTH RECALL IDENTIFIED BY
WHOLESALE RETAIL OR CONSUMER
LEVELS
EFFECTIVNESS MAY REQUIRE NO
FOLLOW UP TO COMPLETE FOLLOW
UP CHECK EVERYONE NOTIFIED OF
RECALL
CHECKS CAN BE MADE BY PERSONAL
VISIT PHONE CALLS OR LETTERS
CUSTOMERS CONTACTED---->AFTER STRATEGY
FINALIZED MANUFACTURER CONTACTS CUSTOMERS BY TELEGRAM,MAILIGRAM OR FIRST CLASS LETTERS W/FOLLOWING INFO:
PRODUCT NAME,SIZE,LOT NO
CODE/SERIAL NO +ANY OTHER
IDENTIFYING INFO
REASON RECALL+HAZARD
INVOLVED
INTRUCTIONS WHAT TO DO W/
PRODUCT BEGINNING W/CEASING
DISTRIBUTION
RECALLS LISTED PUBLICLY--->RECALLS LISTED IN WEEKLY FDA ENFORCEMENT REPORT |
|
|
Term
VOL MED WATCH
1800FDA1088
ACCESSDATA.FDA.GOV/SCRIPTS/MEDWATCH
ALSO BY FAX AND MAIL
FORMS DOWNLOADED FDA.GOV/MEDWATCH/GETFORMS.HTM
ADVERSE REACTIONS TO VACCINES
VACCINE ADVERSE EVENT REPORTING SYSTEM
VAERS
MAINTAINED BY CDC AND FDA
18008227967
WEB SUBISSIONS AND FORMS VAERS.HHS/GOV. |
|
Definition
|
|
Term
FEDERAL LAW PROVIDES FOUNDATION FOR STATE LAWS WHICH GOVERN PHARMACY PRACTICE IN ADDITION TO FDA AND DEA
THERE ARE ALSO FEDERAL LAWS TX OF PTS IN
NURSING HOMES IN RELATION TO VARIOUS ASPECTS OF PHARM PRACTICE IE HIPPPA 1996
EACH STATE THE STATE DEPT OF PROFESSIONAL REGULATION IS RESPONSIBLE FOR LISCENSING ALL PRESCRIBERS AND DISPENSERS AND STATE BOARDS OF PHARM
WHO ADMINISTER STATE REGULATIONS FOR THE PRACTICE OF PHARM IN THAT STATE
IN MANY CASES STATE REG MUCH STRICTER THAN FED AND IT MUST BE FOLLOWED FOLLOWING BOTH FED AND STATE IS MANDATORY
STATES WILL DIFFERENT ON ISSUES IE WHO WILL BE ALLOWED TO PRESCRIBE AS A NON-PHYSICIAN AND WHAT EXTENT OF AUTHORITY
YOUR STATE BOARD OF PHARMACY WILL SHOW ALL YOUR STATES REQUIRMENTS AND REGULATIONS AND YOU SHOULD ATTEND A COPY |
|
Definition
|
|
Term
PHARMACIST RESPONSIBLE FOR ANYTHING DONE BY A PHARM TECH PERFORMANCE IE
ADHERING TO THE LAW AND IF FAILS TO DO SO AND/OR FIX IT SUBJECT TO A PENALTY
BY BOARD OF PHARM MUST ASSURE COMPLIANCE |
|
Definition
|
|
Term
|
Definition
STRICT SET OF RULES
SPECIFIC GUIDELINE FOR PRACTICE |
|
|
Term
|
Definition
MEANS YOU CAN BE PROSECUTED FOR MISCONDUCT TRUE EVEN IF DIRECTED TO DO IT (AND YOU KNOW IT IS NOT CORRECT PRACTICE PROCEDURE NOT YOU SCOPE OF PRACTICE) AND IF YOU FAIL TO DO SOMETHING IE NEGLIGENCE THE MOST COMMON FORM EXAMPLES OF HOW A PHAR TECH MISCONDUCT
INCORRECTLY LABEL SCRIPT
NOT MAINTAIN PT CONFIDENTIALITY
NOT RECOGNIZE EXP DRUGS
CALC ERRORS
DISPENSE WRONG MED
INCORRECT HANDLING SUBSTANCE
INACCURATE RECORDKEEPKING
FOR INFO ON PHAR TECH LIABILITY INS
PHARMACIST MUTUAL PHMIC.COM
HEATHCARE PROVIDERS SERVICE ORGANIZATION (HPSO) HPSO.COM |
|
|
Term
|
Definition
|
|
Term
|
Definition
| FAILING TO DO SOMETHING THT SHOULD OR MUST BE DONE |
|
|
Term
OTHER PROFESSIONAL BODIES AND ASSOC(BESIDES FDA DEA STATE BOARD OF PHARM)
WHICH SET AND MAINTAIN PHARM STANDARD |
|
Definition
ASHP PHARMACISTS,PHARM TECH,PHARM RESIDENCY
USP NOT PROFIT SETS STANDARD MANUFACTURE AND DISTRIBUTION OF DRUG
AND DRUG RELATED PRODUCTS
JCAHO NONPROIT ESTABLISHES STANDARDS
AND MONITORS COMPLIANCE
ASCP SET STANDARDS PRACTICE PHARMACISTS MEDICAL DISTRIBUTION AND
CONSULTANTS SERVICES TO NURSING HOMES |
|
|
Term
| BASIC CRIMINAL AND CIVIL LAWS ALSO APPLY TO PHARM TECHS WHICH MEANS OTHER CRIMES SUCH AS THEFT, ETC STILL PUNISHABLE OUTSIDE THE JOB AS ALL OTHERS |
|
Definition
|
|
Term
|
Definition
FDA LEADING ENFORCEMENT AGENCY FED LEVEL FOR REGULATIONS DRUG/PRODUCTS
DEA JUSTICE LEVEL CONCERNING DRUG DISTRIBUTION OF EASILY ABUSED DRUGS
MANUFACTURER LABEL MUST HAVE RX ONLY
PHARMACISTS MUST OFFER COUNSELING TO PTS FOR MEDS |
|
|
Term
|
Definition
DRUG MUST BE SHOWN TO BE SAFE EFFECTIVE BENEFITS SUBSTANTIALLY OUTWEIGH RISKS
PLACEBO INACTIVE SUBSTANCE USED TO TEST EFFECTIVENESS DRUGS |
|
|
Term
|
Definition
ONCE PATENT BRAND DRUG EXPIRES OTHERS
MAY COPY THE DRUG AND RELEASE IT UNDER ITS GENERIC NAME |
|
|
Term
| KC-3OTC/BEHIND THE COUNTER DRUGS |
|
Definition
SOME KEPT BEHIND THE COUNTER EVEN THOUGH
THEY DO NOT REQUIRE A SCRIPT IE OTC THAT
CONTAINS EPHEDRINE AND PSEUDOEPHEDRINE EXEMPT NARCOTICS AND EMERG CONTRACEPTIVES |
|
|
Term
|
Definition
MIM REQ SCRIPT LABELS FOR MOST AS FOLLOWS:
NAME+ADDRESS DISPENSER
SCRIPT SERIAL NO
DATE SCRIPT OR FILLING
NAME PRESCRIBER
NAME PT
DIRECTIONS FOR USE
CAUTIONARY STATMENTS |
|
|
Term
| KC-3CONTROLLED SUBSTANCES |
|
Definition
MANUFACTERS MUST CLEARLY LABEL CONTROLLED DRUGS W/THIER CLASSIFICATION
ALL PRESCRIBERS OF CONTROLLLED SUBSTANCES MUST REGISTER W/DEA+ASSIGNED DEA NO TO BE USED ON ALL CONTROLLED DRUG SCRIPTS |
|
|
Term
|
Definition
DEA222 MOST FREQ USED BY MANUFACTERS,DISTRIBUTORS,DISPENSERS OF
CONTROLLED SUBSTANCES ALSO TO USE SPECIFIC DEA FORM TO REGISTER W/DEA AND
OTHERWISE MONITOR INVENTORY |
|
|
Term
|
Definition
| RECALLS W/FEW EXCEPTIONS VOLUNTARY ON THE PART OF THE MANUFACTURER |
|
|
Term
|
Definition
FED LAW FOUNDATION
STATE LAW GOVERN IN EACH STATE
STATE BOARD PHARM LICENSING ALL PRESCRIPBERS DISPENSERS +ADMINISTERING
REGULATIONS FOR THE PHARMACY IN THE STATE
LEGAL LIABILITY MEANS YOU CAN BE PROSECTUED FOR MISCONDUCT INCLUDING NEGLIGGENCE |
|
|
Term
| COMBAT METHAMPHETAMINE EPIDEMIC ACT |
|
Definition
| FEDERAL LAW THAT SETS DAILY AND MONTHLY LIMITS ON OTC SALE OF PSEUDOEPHEDRINE AND EPHEDRINE |
|
|
Term
| CONTROLLED SUBSTANCE MARK |
|
Definition
| THE MARK (CII-CV)WHICH INDICATES THE CONTROL CATEGORY OF A DRUG WITH A POTENTIAL FOR ABUSE |
|
|
Term
|
Definition
| STATUS OF MEDS LIKE PLAN B THAT ARE CLASSIFIED AS BOTH SCRIPT DRUGS AND OTC DRUGS |
|
|
Term
|
Definition
| MEDS W/ HABIT FORMING INGREDIENTS THAT CAN BE DISPENSED BY A PHARMACIST WITHOUT A PRESCRIPTION TO PERSONS AT LEAST 18 OR OLDER |
|
|
Term
|
Definition
| ANY DRUG WHICH REQUIRES A JPRESCRIPTION AND THIS LEGEND ON THE LABEL RX ONLY |
|
|
Term
|
Definition
| LEGAL RESPONSIBILITY FOR COSTS OR DAMAGES ARISING FROM MISCONDUCT OR NEGIGENCE |
|
|
Term
|
Definition
| THE NUMBER ON THE MANUFACTURERS LABEL INDICATING THE MANUFACTURER AND PRODUCT INFORMATION |
|
|
Term
|
Definition
| FAILIING TO DO SOMETHING YOU SHOULD HAVE DONE |
|
|
Term
|
Definition
| IMPORTABT ASSOC INFO THAT IS NOT ON THE LABEL OF A DRUG PRODUCT ITSELF |
|
|
Term
|
Definition
| THE ACTION TAKEN TO REMOVE A DRUG FROM THE MARKET AND HAVE IT RETURNED TO THE MANUFACTURER |
|
|
Term
| BOTH DOMESTIC AND IMPORTED DRUGS REQUIRE APPROVAL BY _______ BEFORE MARKETED IN THE US |
|
Definition
|
|
Term
| THE __________PROHIBITED INTERSTATE COMMERCE IN ADULTERATED OR MISBRANDED FOOD DRINK AND DRUGS |
|
Definition
| FOOD AND DRUG ACT OF 1906 |
|
|
Term
| IN RESPONSE TO GROWING ADDICTION TO OPIATES AND COCAINE CONTAINING MEDICINES THE ___________REQUIRED THAT ALL MANUFACTURERS IMPORTERS AND DRS PRESCRIBING NARCOTICS BE _____AND____ |
|
Definition
HARRISON NARCOTIC ACT OF 1914
LICENSED AND TAXED |
|
|
Term
BECAUSE OF FATAL POISONING FROM LIQUID
SULFANILAMIDE THE ________REQUIRED NEW DRUGS TO BE SHOWN TO BE SAFE BEFORE MARKETING |
|
Definition
| 1938 FOOD DRUG AND COSMETIC ACT |
|
|
Term
| THE ___________REQUIRED CHILD PROOF PACKAGING FOR MOST PRESCRIPTION DRUGS |
|
Definition
| POISON PREVENTION PACKAGING ACT |
|
|
Term
| THE MAIN PURPOSE OF PHASE 2 CLINICAL TRIALS IS _________ |
|
Definition
|
|
Term
| THE 1984 HATCH WATCHMAN ACT ALLOWED FOR |
|
Definition
| QUICKER INTO DRUGS AND EXTENTION OF DRUG PATENT TERMS |
|
|
Term
| PHASE 3 CLINICAL TRIALS GENERALLY HAVE ______PARTICIPANTS |
|
Definition
| SEVERAL HUNDRED TO SEVERAL THOUSAND |
|
|
Term
| PHARMACISTIS WERE REQUIRED TO OFFER COUNSELING TO MEDICAID PTS BY THE ________ |
|
Definition
| 1990 OMNIBUS BUDGET RECONCILIATION ACT OBRA |
|
|
Term
| AFTER A PATENT HAS EXP FOR A MED OTHER MANUFACTURERS MAH COPY THE DRUG AND RELEASE IT UNDER THE _____NAME |
|
Definition
|
|
